Prelude Dynamics Announces Its New Patient Event Feature

AUSTIN, TX – December 15, 2016 – Prelude Dynamics announces VISION’s latest enhancement Prelude Dynamic announces the addition of a new feature to its Premier Clinical Trial Optimization Platform, VISION™. The new feature allows users to view the...

VISION Supported Xeris Pharmaceuticals in Diabetes Drug Research

Austin, Texas – Xeris Pharmaceuticals recently announced the completion of its Series B stock offering which will allow the commercialization of their newest Diabetes Injectable Drug offerings. The funding will be used to promote their G-Pen (a glucagon injectable)....

Introducing VISION™ 9

AUSTIN, TX – December 15, 2016 – Prelude Dynamics announces its release of VISION™ 9. VISION™ is Prelude’s Clinical Trial Optimization Platform that goes beyond EDC. The launch of VISION™ 9 has generated much excitement. It’s new features...

Handling a Surgical Study with Repeated Observation Times

  Challenge   While collecting repeated observations of animals using a standardize scale is not in itself a challenge, allowing access to only one scale at a time during the appropriate time frame to the correct individual is a challenge. For this particular study,...
Page 2 of 3123